Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat

Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat

Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...

Full description

Bibliographic Details
Main Authors: M Teixeira, P Rodrigues-Santos, P Garrido, E Costa, B Parada, J Sereno, R Alves, L Belo, F Teixeira, A Santos-Silva, F Reis
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Apoptosis
cardiovascular protection
gene expression
moderate chronic renal failure
proliferation/angiogenesis
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2012;volume=4;issue=1;spage=76;epage=83;aulast=Teixeira

Internet

http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2012;volume=4;issue=1;spage=76;epage=83;aulast=Teixeira

Similar Items